Neoadjuvant Ipilimumab in Prostate Cancer

Clinical trial NCT01194271 · COMPLETED

Trial details

NCT number: NCT01194271
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2010-09-01
Primary completion: 2015-10-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.